122 related articles for article (PubMed ID: 22938479)
1. HER2/neu expression in head and neck squamous cell carcinoma patients is not significantly elevated.
Sardari Y; Pardis S; Tadbir AA; Ashraf MJ; Fattahi MJ; Ebrahimi H; Purshahidi S; Khademi B; Hamzavi M
Asian Pac J Cancer Prev; 2012; 13(6):2891-6. PubMed ID: 22938479
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of Tissue Expression and Salivary Levels of HER2/neu in Patients with Head and Neck Squamous cell Carcinoma.
Pardis S; Sardari Y; Ashraf MJ; Andisheh Tadbir A; Ebrahimi H; Purshahidi S; Khademi B; Fattahi MJ; Hamzavi M
Iran J Otorhinolaryngol; 2012; 24(69):161-70. PubMed ID: 24303404
[TBL] [Abstract][Full Text] [Related]
3. Prognostic impact of HER-2/neu expression on squamous head and neck carcinomas.
Cavalot A; Martone T; Roggero N; Brondino G; Pagano M; Cortesina G
Head Neck; 2007 Jul; 29(7):655-64. PubMed ID: 17315173
[TBL] [Abstract][Full Text] [Related]
4. Human epidermal growth factor receptor 2 neu expression in head and neck squamous cell cancers and its clinicopathological correlation: Results from an Indian cancer center.
Vats S; Ganesh MS; Agarwal A
Indian J Pathol Microbiol; 2018; 61(3):313-318. PubMed ID: 30004046
[TBL] [Abstract][Full Text] [Related]
5. HER-2/neu oncogene characterization in head and neck squamous cell carcinoma.
Beckhardt RN; Kiyokawa N; Xi L; Liu TJ; Hung MC; el-Naggar AK; Zhang HZ; Clayman GL
Arch Otolaryngol Head Neck Surg; 1995 Nov; 121(11):1265-70. PubMed ID: 7576473
[TBL] [Abstract][Full Text] [Related]
6. Salivary Her2/neu Levels in Differentiation of Oral Premalignant Disorders and Oral Squamous Cell Carcinomas.
Varun C; Dineshkumar T; Jayant VS; Rameshkumar A; Rajkumar K; Rajashree P; Mathew J; Arunvignesh RK
Asian Pac J Cancer Prev; 2015; 16(14):5773-7. PubMed ID: 26320450
[TBL] [Abstract][Full Text] [Related]
7. Membranous expression of Her3 is associated with a decreased survival in head and neck squamous cell carcinoma.
Takikita M; Xie R; Chung JY; Cho H; Ylaya K; Hong SM; Moskaluk CA; Hewitt SM
J Transl Med; 2011 Jul; 9():126. PubMed ID: 21801427
[TBL] [Abstract][Full Text] [Related]
8. Increased Expression of HER2, HER3, and HER2:HER3 Heterodimers in HPV-Positive HNSCC Using a Novel Proximity-Based Assay: Implications for Targeted Therapies.
Pollock NI; Wang L; Wallweber G; Gooding WE; Huang W; Chenna A; Winslow J; Sen M; DeGrave KA; Li H; Zeng Y; Grandis JR
Clin Cancer Res; 2015 Oct; 21(20):4597-606. PubMed ID: 26138066
[TBL] [Abstract][Full Text] [Related]
9. Expression of Human Epidermal Growth Factor Receptor (Her 2/neu) and Proliferative Marker Ki-67: Association with Clinicopathological Parameters in Gallbladder Carcinoma.
Pujani M; Makker I; Makker A; Jetley S; Goel MM; Jetley S
Asian Pac J Cancer Prev; 2016; 17(8):3903-9. PubMed ID: 27644637
[TBL] [Abstract][Full Text] [Related]
10. Tissue expression, serum and salivary levels of IL-10 in patients with head and neck squamous cell carcinoma.
Hamzavi M; Tadbir AA; Rezvani G; Ashraf MJ; Fattahi MJ; Khademi B; Sardari Y; Jeirudi N
Asian Pac J Cancer Prev; 2013; 14(3):1681-5. PubMed ID: 23679256
[TBL] [Abstract][Full Text] [Related]
11. Pharmacodiagnostic value of the HER family in head and neck squamous cell carcinoma.
Schartinger VH; Kacani L; Andrle J; Schwentner I; Wurm M; Obrist P; Oberaigner W; Sprinzl GM
ORL J Otorhinolaryngol Relat Spec; 2004; 66(1):21-6. PubMed ID: 15103197
[TBL] [Abstract][Full Text] [Related]
12. Tissue expression, serum and salivary levels of vascular endothelial growth factor in patients with HNSCC.
Andisheh-Tadbir A; Hamzavi M; Rezvani G; Ashraf MJ; Fattahi MJ; Khademi B; Kamali F
Braz J Otorhinolaryngol; 2014; 80(6):503-7. PubMed ID: 25457070
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of Cyclin D1 and Human Epidermal Growth Factor Receptor 2 Neu Protein Expression in Head and Neck Squamous Cell Carcinoma.
Sinha S; Das S; Mohiyuddin SMA
Cureus; 2023 Feb; 15(2):e35526. PubMed ID: 37007344
[TBL] [Abstract][Full Text] [Related]
14. Serum level and tissue expression of c-erbB-1 and c-erbB-2 proto-oncogene products in patients with squamous cell carcinoma of the head and neck.
Hoffmann TK; Balló H; Braunstein S; Van Lierop A ; Wagenmann M; Bier H
Oral Oncol; 2001 Jan; 37(1):50-6. PubMed ID: 11120483
[TBL] [Abstract][Full Text] [Related]
15. Activated leukocyte cell adhesion molecule (ALCAM/CD166) expression in head and neck squamous cell carcinoma (HNSSC).
Clauditz TS; von Rheinbaben K; Lebok P; Minner S; Tachezy M; Borgmann K; Knecht R; Sauter G; Wilczak W; Blessmann M; Münscher A
Pathol Res Pract; 2014 Oct; 210(10):649-55. PubMed ID: 25028217
[TBL] [Abstract][Full Text] [Related]
16. Correlation of matrix metalloproteinase-2, -9, tissue inhibitor-1 of matrix metalloproteinase and CD44 variant 6 in head and neck cancer metastasis.
Xu YP; Zhao XQ; Sommer K; Moubayed P
J Zhejiang Univ Sci; 2003; 4(4):491-501. PubMed ID: 12861629
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of HER-2/neu overexpression in gastric carcinoma using a tissue microarray.
Rakhshani N; Kalantari E; Bakhti H; Sohrabi MR; Mehrazma M
Asian Pac J Cancer Prev; 2014; 15(18):7597-602. PubMed ID: 25292034
[TBL] [Abstract][Full Text] [Related]
18. Expression of immunohistochemical markers in non-oropharyngeal head and neck squamous cell carcinoma in Ghana.
Owusu-Afriyie O; Owiredu WKBA; Owusu-Danquah K; Komarck C; Foltin SK; Larsen-Reindorf R; Acheampong E; Quayson SE; Prince MEP; McHugh JB; Donkor P; Merajver SD; Brenner JC
PLoS One; 2018; 13(8):e0202790. PubMed ID: 30138436
[TBL] [Abstract][Full Text] [Related]
19. An investigation of the differential expression of Her2/neu gene expression in normal oral mucosa, epithelial dysplasia, and oral squamous cell carcinoma in Taiwan.
Fong Y; Chou SJ; Hung KF; Wu HT; Kao SY
J Chin Med Assoc; 2008 Mar; 71(3):123-7. PubMed ID: 18364263
[TBL] [Abstract][Full Text] [Related]
20. Blockade of adenosine A2A receptor enhances CD8
Ma SR; Deng WW; Liu JF; Mao L; Yu GT; Bu LL; Kulkarni AB; Zhang WF; Sun ZJ
Mol Cancer; 2017 Jun; 16(1):99. PubMed ID: 28592285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
